Literature DB >> 3924488

Pleuro-pulmonary manifestations of systemic lupus erythematosus: clinical features of its subgroups. Prognostic and therapeutic implications.

A Pines, N Kaplinsky, D Olchovsky, J Rozenman, O Frankl.   

Abstract

Correct identification of the subsets of pulmonary lupus has an unquestioned importance in planning the proper therapeutic regimen in this extremely variegated disease. Asymptomatic pulmonary lupus needs no treatment; however, pulmonary involvement in lupus may be life threatening, in which case prompt and aggressive treatment is mandatory. The different aspects of pulmonary lupus are demonstrated through the clinical histories of patients who suffered from pleuro-pulmonary lupus. The following entities are presented: lupus pneumonitis, lymphocytic interstitial pneumonia, pulmonary hypertension, pulmonary hemorrhage, pulmonary embolism associated with circulating lupus anticoagulant, lupus pleuritis and weakness of the diaphragm.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3924488     DOI: 10.1378/chest.88.1.129

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  12 in total

Review 1.  Imaging of the pulmonary manifestations of systemic disease.

Authors:  A G Rockall; D Rickards; P J Shaw
Journal:  Postgrad Med J       Date:  2001-10       Impact factor: 2.401

Review 2.  Lymphocytic interstitial pneumonitis (LIP) in Sjögren's syndrome: a case report and a review of the literature.

Authors:  Vrishali Dalvi; Emilio B Gonzalez; Louis Lovett
Journal:  Clin Rheumatol       Date:  2006-08-05       Impact factor: 2.980

3.  False positive pleural biopsy and high CA125 levels in serum and pleural effusion in systemic lupus erythematosus.

Authors:  A E Yucel; M Calguneri; S Ruacan
Journal:  Clin Rheumatol       Date:  1996-03       Impact factor: 2.980

4.  An unusual case of systemic lupus erythematosus with isolated hypoglossal nerve palsy, fulminant acute pneumonitis, and pulmonary amyloidosis.

Authors:  C N Chan; E Li; F M Lai; J A Pang
Journal:  Ann Rheum Dis       Date:  1989-03       Impact factor: 19.103

5.  Bilateral pneumothorax and mediastinal emphysema in systemic lupus erythematosus.

Authors:  S O Paira; S Roverano
Journal:  Clin Rheumatol       Date:  1992-12       Impact factor: 2.980

6.  Systemic lupus erythematosus: clinical manifestations and immunological parameters in 194 patients. Subgroup classification of SLE.

Authors:  J Antolin; M J Amerigo; A Cantabrana; A Roces; P Jimenez
Journal:  Clin Rheumatol       Date:  1995-11       Impact factor: 2.980

7.  False positive pleural biopsy and high CA125 levels in serum and pleural effusion in systemic lupus erythematosus.

Authors:  A E Yücel; M Calguneri; S Ruacan
Journal:  Clin Rheumatol       Date:  1996-05       Impact factor: 2.980

8.  Gas transfer and pulmonary function tests in women with disseminated lupus erythematosus.

Authors:  Babak Amra; Bijan Iraj; Zahra Seyyed Benakdar; Hamid Sanei; Golshan Mohammad
Journal:  ARYA Atheroscler       Date:  2012

9.  Lupus pneumonitis presenting with high titre of anti-Ro antibody.

Authors:  Mei-Chuan Chen; Yueh-Lin Wu; Kai-Ling Lee; Kevin S Lai; Chi-Li Chung
Journal:  Respirol Case Rep       Date:  2017-10-27

Review 10.  Shrinking lung syndrome in systemic lupus erythematosus: A case series and review of the literature.

Authors:  Helena Borrell; Javier Narváez; Juan José Alegre; Ivan Castellví; Francesca Mitjavila; María Aparicio; Eulàlia Armengol; María Molina-Molina; Joan M Nolla
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.